{
    "title": "110_hr194",
    "content": "The Act titled \"Prescription Drug Affordability Act\" introduces an income tax credit for prescription drugs purchased by individuals who have reached retirement age. This amendment to the Internal Revenue Code of 1986 aims to provide financial relief for seniors in purchasing necessary medications. The \"Prescription Drug Affordability Act\" introduces an income tax credit for individuals at social security retirement age. The credit allows for 80% of prescription drug costs to be deducted from the taxpayer's tax liability. The credit coordinates with the medical expense deduction to avoid double benefits. The tax credit introduced in the \"Prescription Drug Affordability Act\" allows individuals at social security retirement age to deduct 80% of prescription drug costs from their tax liability. The credit does not apply to amounts paid from Archer MSAs or health savings accounts, and taxpayers can choose not to have the credit apply for a taxable year. Title II of the Act includes amendments to the Federal Food, Drug, and Cosmetic Act, specifically focusing on the facilitation of drug importation approved by the FDA. The effective date for these changes is set to be more than 1 year after the enactment of the Act. The Federal Food, Drug, and Cosmetic Act is amended to allow importation of certain drugs by individuals meeting legal requirements without being the manufacturer, upon approval by the Secretary. The drugs must be subject to specific sections or contain insulin. The Secretary will approve an application for drug importation if it meets all requirements, including approval under section 505 or 351 of the Public Health Service Act, and if the drug is not adulterated or misbranded. The Secretary must approve or refuse the application within 60 days and this does not affect any patent rights. The paragraph states that it does not affect any patent rights. Amendments are made to the Federal Food, Drug, and Cosmetic Act regarding redesignating paragraphs and updating references within the text. SEC. 202. INTERNET SALES OF PRESCRIPTION DRUGS. Section 503(b) of the Federal Food, Drug, and Cosmetic Act is amended to allow interstate sale of prescription drugs through an Internet site if the sale complies with federal and state laws, and accurate compliance information is posted on the site. The amendment to Section 503(b) of the Federal Food, Drug, and Cosmetic Act allows for the interstate sale of prescription drugs through an Internet site, as long as it complies with federal and state laws. The sale must involve introducing the drug into interstate commerce or delivering it for introduction into such commerce. The term 'prescription drug' refers to a drug subject to paragraph (1) of the Act. The Secretary of Health and Human Services must create regulations to implement the changes to the Federal Food, Drug, and Cosmetic Act within a specified time period. The amendments made by sections 201 and 202 will take effect one year after the enactment of the Act, regardless of whether the regulations have been finalized."
}